Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    Hypersomnia
Show Display Options
Rank Status Study
1 Unknown  Amylase and Hypersomnia
Condition: Hypersomnia in Children
Intervention: Procedure: saliva collection
2 Completed
Has Results
Clarithromycin for the Treatment of Hypersomnia
Conditions: Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy
Interventions: Drug: Clarithromycin followed by placebo;   Drug: Placebo then Clarithromycin
3 Enrolling by invitation Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia
Conditions: Narcolepsy;   Cataplexy
Intervention: Device: Polysomnography
4 Completed
Has Results
Flumazenil for the Treatment of Primary Hypersomnia
Conditions: Hypersomnia;   Primary Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Intervention: Drug: Flumazenil
5 Recruiting Neurophysiologic Correlates of Hypersomnia
Conditions: Major Depressive Disorder;   Primary Hypersomnia;   Bipolar Disorder;   Narcolepsy;   Primary Insomnia
Intervention: Other: Acoustical slow wave induction
6 Recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
7 Completed
Has Results
Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder
Condition: Excessive Sleepiness
Interventions: Drug: armodafinil;   Drug: placebo
8 Completed
Has Results
Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder
Condition: Excessive Sleepiness
Interventions: Drug: Armodafinil;   Drug: Matching Placebo
9 Completed
Has Results
Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
Conditions: Excessive Sleepiness;   Shift Work Sleep Disorder
Interventions: Drug: Armodafinil 150 mg/day;   Drug: Placebo
10 Recruiting Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Sleepiness
Interventions: Drug: JZP-110;   Drug: Placebo
11 Recruiting Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA
Conditions: Obstructive Sleep Apnea;   Excessive Sleepiness
Interventions: Drug: JZP-110;   Drug: Placebo
12 Completed
Has Results
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
Conditions: Sleep Disorders;   Obstructive Sleep Apnea;   Major Depressive Disorder;   Dysthymic Disorder
Interventions: Drug: armodafinil;   Drug: placebo
13 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Modafinil
14 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
15 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome
Condition: Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
16 Completed
Has Results
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Armodafinil;   Drug: Placebo
17 Completed
Has Results
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
Conditions: Obstructive Sleep Apnea;   Sleep Hypopnea
Interventions: Drug: Armodafinil 150 mg/day;   Drug: Placebo
18 Completed
Has Results
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)
Conditions: Obstructive Sleep Apnea;   Hypopnea
Interventions: Drug: Armodafinil 250 mg/day;   Drug: Armodafinil 150 mg/day;   Drug: Placebo
19 Completed VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
Condition: Excessive Somnolence
Intervention: Drug: VSF-173
20 Active, not recruiting "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
Condition: Obstructive Sleep Apnea
Intervention: Drug: JZP-110

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.